STOCK TITAN

If You Invested in ROYAL BK CDA 1ST PFD BO (RYLBF)

Financial Services · Banks - Diversified · OTC
Looking for the current price? See the RYLBF quote & overview
$1,000 invested 1 Year Ago
$1,026
+2.6% price return 5.0% CAGR
Bought on Oct 24, 2025 at $19.00 split-adjusted
$1,000 invested 5 Years Ago
N/A
Trading since 2023-11-22

What $1,000 or $10,000 in RYLBF Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Nov 22, 2023
$1,000 $1,026 +3% — — $1,247 +25%
$10,000 $10,262 +3% — — $12,475 +25%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-05-04. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for RYLBF

$1,000 Investment Over Time

RYLBF vs S&P 500

Year-by-Year Returns

RYLBF annual performance
Year Start Price End Price Annual Return Cumulative
2023 $15.63 $16.67 +6.7% +6.7%
2024 $16.67 $18.19 +9.1% +16.4%
2025 $18.19 $18.64 +2.4% +19.2%
2026 $18.64 $19.50 +4.6% +24.7%

About ROYAL BK CDA 1ST PFD BO

Financial Services · OTC

ROYAL BK CDA 1ST PFD BO (RYLBF) represents a series of first preferred shares of Royal Bank of Canada. The SEC filings provided identify Royal Bank of Canada as the registrant and issuer associated with this security. Royal Bank of Canada submits reports to the U.S. Securities and Exchange Commission as a foreign private issuer, and those reports cover matters such as annual reporting, earnings releases, and capital markets transactions.

According to multiple Form 6-K filings furnished under the Securities Exchange Act of 1934, Royal Bank of Canada files under Form 40-F. These filings are described as current reports of a foreign issuer and are used to provide information to U.S. investors that has been made public in the issuer’s home jurisdiction or is otherwise material. The documents associated with these filings include a notification of meeting and record date for common shareholders, a 2025 Annual Report, an Independent Auditor’s Report, and a Fourth Quarter 2025 earnings release.

The filings list principal executive offices for Royal Bank of Canada in Toronto, Ontario, Canada, and in Montreal, Quebec, Canada. The address blocks in the 6-Ks identify Royal Bank Plaza in Toronto and 1 Place Ville Marie in Montreal as locations for the Vice President, Associate General Counsel and Corporate Secretary or Secretary. This indicates that Royal Bank of Canada maintains executive and legal functions in both Toronto and Montreal, as reflected in its SEC submissions.

Several of the 6-K reports state that they are incorporated by reference into a registration statement on Form F-3 (File No. 333-275898) for Royal Bank of Canada. In one such filing, the exhibits are described as being filed in connection with the issuance of Senior Global Medium-Term Notes, Series J. The exhibits include opinions from legal counsel on the validity of the notes under New York law, opinions on matters of Canadian, Ontario and Québec law, and opinions on certain aspects of United States and Canadian federal income taxation, along with related consents.

The notes referenced in those filings include senior fixed rate/floating rate notes and senior floating rate notes with specified due dates. The description of these instruments in the exhibits section of the 6-K shows that Royal Bank of Canada uses the U.S. capital markets to issue senior global medium-term notes under its shelf registration statement. The opinions and consents from U.S. and Canadian counsel are filed as exhibits to support those offerings from a legal and tax perspective.

For investors reviewing RYLBF, the available SEC information shows that the security is tied to Royal Bank of Canada’s broader reporting framework as a foreign private issuer. The 6-K filings demonstrate that Royal Bank of Canada provides U.S. investors with access to its annual report, audited financial information, quarterly earnings releases, and documentation related to specific securities offerings. While the filings cited do not describe the detailed terms of the RYLBF preferred shares themselves, they establish the regulatory context in which Royal Bank of Canada communicates with investors.

Because the provided data focuses on SEC filings rather than a narrative business description, the emphasis for RYLBF on this page is on how Royal Bank of Canada interacts with the U.S. disclosure system, the types of documents it files, and the locations of its principal executive offices as presented in those filings.

Key regulatory documents referenced

  • Form 6-K current reports furnished under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
  • Form 40-F designation for Royal Bank of Canada as a foreign private issuer.
  • Notification of meeting and record date for common shareholders (filed as Exhibit 99.1).
  • 2025 Annual Report (filed as Exhibit 99.1 in a separate 6-K).
  • Independent Auditor’s Report (filed as Exhibit 99.1 in another 6-K).
  • Fourth Quarter 2025 earnings release (filed as Exhibit 99.1 in a further 6-K).
  • Exhibits related to Senior Global Medium-Term Notes, Series J, including legal and tax opinions and consents.
Current Price
$19.50
EPS
$10.04
Revenue
$47.5B
Net Margin
30.6%
View full RYLBF overview

Frequently Asked Questions

ROYAL BK CDA 1ST PFD BO investment returns

How much would $1,000 invested in ROYAL BK CDA 1ST PFD BO be worth today?

If you invested $1,000 in ROYAL BK CDA 1ST PFD BO (RYLBF) 1 years ago on 2025-10-24, your investment would be worth $1,026 as of 2026-05-04, a +2.6% price return without dividends, growing at a compounded rate of 5.0% per year (CAGR).

Has ROYAL BK CDA 1ST PFD BO outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare RYLBF performance over available time periods.

For informational and educational purposes only, not investment advice.